Suppr超能文献

甲状旁腺激素(1-34)在体外影响人牙周膜细胞中骨保护素的产生。

PTH(1-34) affects osteoprotegerin production in human PDL cells in vitro.

作者信息

Lossdörfer S, Götz W, Jäger A

机构信息

Department of Orthodontics, Dental Clinic, University of Bonn, Welschnonnenstrasse 17, 53111 Bonn, Germany.

出版信息

J Dent Res. 2005 Jul;84(7):634-8. doi: 10.1177/154405910508400710.

Abstract

Since periodontal ligament (PDL) cells exhibit several osteoblastic traits, we hypothesized that human PDL cells will respond to hormonal stimulation in an osteoblast-like manner. Confluent and pre-confluent PDL cells from six patients were challenged with PTH(1-34). Cell number, ALP, osteocalcin, osteoprotegerin, and RANKL expression were determined. Intermittent PTH(1-34) treatment of confluent PDL cells caused a significant increase in proliferation, whereas differentiation and osteoprotegerin production decreased significantly. In pre-confluent PDL cells, this treatment regimen induced a biphasic decrease in proliferation, but a biphasic increase in differentiation and osteoprotegerin production. Continuous PTH(1-34) exposure enhanced proliferation but inhibited osteocalcin production in confluent cells and stimulated osteoprotegerin production in pre-confluent PDL cells. RANKL was hardly detectable and unaffected by PTH(1-34) treatment. These results indicate that human PDL cells respond to PTH(1-34) in an osteoblast-like manner, and that the PTH(1-34) effect depends on the maturation state of the cells and on the mode of administration.

摘要

由于牙周膜(PDL)细胞表现出几种成骨细胞特征,我们推测人牙周膜细胞将以成骨细胞样方式对激素刺激作出反应。来自6名患者的融合和预融合牙周膜细胞用甲状旁腺激素(1-34)进行刺激。测定细胞数量、碱性磷酸酶(ALP)、骨钙素、骨保护素和核因子κB受体活化因子配体(RANKL)的表达。对融合的牙周膜细胞进行间歇性甲状旁腺激素(1-34)处理导致增殖显著增加,而分化和骨保护素产生则显著减少。在预融合的牙周膜细胞中,这种处理方案诱导增殖呈双相性降低,但分化和骨保护素产生呈双相性增加。持续暴露于甲状旁腺激素(1-34)可增强融合细胞的增殖,但抑制骨钙素产生,并刺激预融合牙周膜细胞产生骨保护素。RANKL几乎检测不到,且不受甲状旁腺激素(1-34)处理的影响。这些结果表明,人牙周膜细胞以成骨细胞样方式对甲状旁腺激素(1-34)作出反应,并且甲状旁腺激素(1-34)的作用取决于细胞的成熟状态和给药方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验